SMTL ID : 6xta.1

Recombinant human butyrylcholinesterase in complex with (2S)-N-[2-(1-benzylazepan-4-yl)ethyl]-2-(butylamino)-3-(1H-indol-3-yl)propanamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.50 Å
Oligo State
monomer
Ligands
2 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- TGY: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[1-deoxy-alpha-D-tagatopyranose-(2-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x O0Z: (2~{S})-2-(butylamino)-3-(1~{H}-indol-3-yl)-~{N}-[2-[(4~{R})-1-(phenylmethyl)azepan-4-yl]ethyl]propanamide(Non-covalent)
2 x SO4: SULFATE ION(Non-functional Binders)
1 x CL: CHLORIDE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Meden, A. et al., Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors. Eur.J.Med.Chem. (2020)
Release Date
2020-10-28
Peptides
Cholinesterase: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Cholinesterase

Related Entries With Identical Sequence

1p0i.1 | 1p0i.2 | 1p0i.3 | 1p0m.1 | 1p0p.1 | 1p0p.2 | 1p0q.1 | 1xlu.1 | 1xlu.2 | 1xlv.1 | 1xlv.2 | 1xlw.1 | 1xlw.2 | 2wsl.1 | 3djy.1 | 3djy.2 | 3dkk.1 | 3dkk.2 | 4bds.1 | 6ep4.1 | 6eqp.1 | 6eqq.1 | 6i0b.1 | 6i0c.1 | 6sam.1 | 6t9p.1 | 6t9p.2 | 6t9s.1 | 6zwi.1 | 7amz.1  more...